Proton pump inhibitor therapy after Helicobacter pylori eradication may increase the risk of gastric cancer | BMJ Evidence-Based Medicine

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Commentary

General medicine

Proton pump inhibitor therapy after Helicobacter pylori eradication may increase the risk of gastric cancer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Tan MC, Graham DY

Proton pump inhibitor therapy after Helicobacter pylori eradication may increase the risk of gastric cancer

BMJ Evidence-Based Medicine 2018;23:111-112.